Mercanto HoldingsTGSHF 34 Return-on-Tangible-Equity is 113.91% as of Apr. 2026. GuruFocus rates TGSHF with a GF Score™ of 34/100. The stock has 2 warning signs investors should review. Among 895 Drug Manufacturers companies, Mercanto Holdings ranks worse than 74.08% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Mercanto Holdings's annualized net income for the quarter that ended in Apr. 2026 was $0.35 Mil. Mercanto Holdings's average shareholder tangible equity for the quarter that ended in Apr. 2026 was $0.31 Mil. Therefore, Mercanto Holdings's annualized Return-on-Tangible-Equity for the quarter that ended in Apr. 2026 was 113.91%.
The historical rank and industry rank for Mercanto Holdings's Return-on-Tangible-Equity or its related term are showing as below:
TGSHF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -213.36 Med: -99.88 Max: 7.88
Current: -2.22
During the past 5 years, Mercanto Holdings's highest Return-on-Tangible-Equity was 7.88%. The lowest was -213.36%. And the median was -99.88%.
TGSHF's Return-on-Tangible-Equity is ranked worse than 74.08% of 895
companies
in the Drug Manufacturers industry
Industry Median: 7.89
vs TGSHF: -2.22
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Mercanto Holdings Return-on-Tangible-Equity Related Terms
Mercanto Holdings Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Mercanto Holdings's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TGSHF vs ZTS, UTHR: Return-on-Tangible-Equity Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Mercanto Holdings's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mercanto Holdings Return-on-Tangible-Equity vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Mercanto Holdings's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Mercanto Holdings's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Apr. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 113.91% mean?
Mercanto Holdings (TGSHF) has a Return-on-Tangible-Equity of 113.91% as of Apr. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Mercanto Holdings and its competitors. According to the industry distribution chart, Mercanto Holdings ranks #663 out of 895 companies in the Drug Manufacturers industry, placing it in the top 74.1%.
Is Mercanto Holdings' Return-on-Tangible-Equity too high?
Mercanto Holdings' current Return-on-Tangible-Equity is 113.91%. The Drug Manufacturers industry median Return-on-Tangible-Equity is 7.89. Mercanto Holdings' value of 113.91% is 1343.7% above this industry median. Based on the distribution chart, Mercanto Holdings ranks #663 out of 895 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Mercanto Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Mercanto Holdings' Return-on-Tangible-Equity compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Mercanto Holdings ranks #663 out of 895 companies for Return-on-Tangible-Equity. This places Mercanto Holdings in the lower half of its industry. The industry median Return-on-Tangible-Equity is 7.89. Mercanto Holdings' value of 113.91% is 1343.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Drug Manufacturers company?
The median Return-on-Tangible-Equity among Drug Manufacturers companies is 7.89, based on 895 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mercanto Holdings's current Return-on-Tangible-Equity of 113.91% is 1343.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Mercanto Holdings and its competitors. For the Drug Manufacturers industry, the median Return-on-Tangible-Equity is 7.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mercanto Holdings's current Return-on-Tangible-Equity is 113.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercanto Holdings stock overvalued right now?
Mercanto Holdings (TGSHF) has a current Return-on-Tangible-Equity of 113.91%. The current Return-on-Tangible-Equity is 113.91% and 1343.7% above the Drug Manufacturers industry median of 7.89. Mercanto Holdings' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Mercanto Holdings (TGSHF), the current Return-on-Tangible-Equity is 113.91% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Mercanto Holdings Inc operates a portfolio of brands that include traditional cannabis and beverage products. The company exists to promote the use of mushrooms through its brands; The company offers quality products that promote health, recreation, and well-being. The portfolio of the company includes different cannabis products, probiotic, functional mushroom beverages, and others.
34GF Score
Get the complete analysis for TGSHF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TGSHF has been successfully added to your 
